1. Maria Vergoulidou, Lothar Krause, Michael H. Foerster, Eckhard Thiel, Stefan Schwartz. Endogenous filamentous fungal endophthalmitis – single-centre survey in patients with acute leukaemia or postallogeneic stem cell transplantation and review of the literature. Mycoses 2011; 54(6):e704-711. Impact factor 1.667 (2010) 

2. Westhoff T*, Vergoulidou M*, Loddenkemper C, Schwartz S, Schneider T, Zidek W, van der Giet M. Chronic norovirus infection in renal transplant recipients. Nephrology Dialysis and Transplantation 2009; 24(3):1051-1053. (*shared first authorship) Impact factor 3.306 

3. Stefan Schwartz, Maria Vergoulidou, Eckart Schreier, Christoph Loddenkemper, Mark Reinwald, Martin Schmidt-Hieber, Willy A. Flegel, Eckhard Thiel, Thomas Schneider. Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation. Blood 2011; 117(22):5850-5856. Impact factor 10.558 (2010)

4. Vergoulidou M. More than a decade of tyrosine kinase inhibitors in the treatment of solid tumors: what we have learned and what the future holds. Biomark Insights. 2015 Oct 8;10(Suppl 3):33-40.

5. Koehler P, Hamprecht A, Bader O, Bekeredjian-Ding I, Buchheidt D, Doelken G, Elias J, Haase G, Hahn-Ast C, Karthaus M, Kekulé A, Keller P, Kiehl M, Krause SW, Krämer C, Neumann S, Rohde H, La Rosée P, Ruhnke M, Schafhausen P, Schalk E, Schulz K, Schwartz S, Silling G, Staib P, Ullmann A, Vergoulidou M, Weber T, Cornely OA, Vehreschild MJ. Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study. Int J Antimicrob Agents. 2017 Feb;49(2):218-223. 

6. Vergoulidou M. Leptomeningeal Carcinomatosis in Gastric Cancer: A Therapeutical Challenge. Biomark Insights. 2017 Mar 16;12:1177271917695237. 

Book articles: 

Indications for Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors (Chapter), In book: Resistance to Tyrosine Kinase Inhibitors, pp.179-188, January 2016, DOI: 10.1007/978-3-319-46091-8_7